This Business Plan addresses a complex industry and covers a diverse range of contexts across our 54 member states. Strengthening our ability to produce high quality, affordable pharmaceuticals across all essential medicines will contribute to improved health outcomes
and the realization of direct and indirect economic bene!ts. This is the vision of the Pharmaceutical Manufacturing Plan for Africa (PMPA) endorsed by our Heads of State and Government at the summit in Accra in 2007. This Business Plan outlines a recommended
approach for achieving these aims.